TRAW
TRAW
NASDAQ · Pharmaceuticals

Traws Pharma Inc

$0.51
+0.01 (+1.08%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +4,302.2% upside
Low Target $15.33
Average Target $22.24
High Target $34.90
Current Price $0.51
Current
$0.51
Target
$22.24
$15.33 $22.24 avg $34.90
Scenario Analysis
Bear Case
$15.33
2,934.4%
Low target
Base Case
$22.24
+4,302.2%
Avg target
Bull Case
$34.90
+6,808.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.27
-84.5% from high
52-Week Low
$0.43
+17.5% from low
Target vs 52W High
$22.24
+581.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%